Actions Panel
Imperial Neurotechnology 2016
Date and time
Location
Imperial College
228 Royal School of Mines Building Prince Consort Road London SW7 2BP United KingdomDescription
Centre for Neurotechnology Annual Research Symposium
A day of talks and posters showcasing Neurotechnology research at Imperial and beyond.
Download the event programme for full abstracts and directions to the symposium.
Schedule
09.30 Arrival and coffee
09.50 Welcome from Simon Schultz, Centre Director
10.00 Plenary talk – James Fawcett, University of Cambridge
Restoring function after spinal cord injury
10.45 Paul Chadderton, Imperial College
Encoding of voluntary movement by a neuronal machine
11.15 Break
11.35 Nadia Malik, Eli Lilly & Co
Title tbc
12.05 CDT Neurotechnology student talks - Diana Lucaci & Peter Quicke
Measuring local and distant synaptic connectivity in the brain during ageing
Synaptic connectivity measurements using genetically encoded voltage indicators
12.45 Lunch and poster session
14.15 Plenary talk – Wouter Serdijn, Delft University of Technology
Getting better with electroceuticals; implantable and injectable electronics to the rescue
15.00 Dan Goodman, Imperial College
Localising sounds in the real world
15.30 Break
15.50 Timothy O'Leary, University of Cambridge
How do neurons control their properties?
16.20 David Sharp, Imperial College
Predicting and preventing traumatic brain injury
16.50 Discussion + Q&A session on CDT Neurotechnology project call 2017/18
17.15 Drinks reception
Please note that places are normally restricted to members of Imperial College and those with an association with the College.
Click to view Eventbrite's terms and conditions and privacy policy with regard to use of your data (links to these are also available during the registration process).
Organised by
The Imperial College Centre of Excellence in Neurotechnology fosters collaborative research at the interface of neuroscience and engineering, with the aim of advancing our understanding of brain function and producing new technologies in order to reduce the burden of brain disorders on society and improve the quality of life and health in the UK.